3 completed, 3 unknown. .
Follow HBI Solutions Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Blood Test to Diagnose Kawasaki Disease Kawasaki Disease | Unknown | HBI Solutions Inc. | 800 | 2023-07-01 | 2023-03-23 | |
| Cohort Study to Evaluate the Relapse Risk Test in Colorectal Cancer Colorectal Cancer | Unknown | HBI Solutions Inc. | 1000 | 2023-05-01 | 2023-03-23 | |
| Development and Validation of a Multi-target, Blood-based NAFLD Diagnosis Test NAFLD, NASH - Nonalcoholic Steatohepatitis | Unknown | HBI Solutions Inc. | 1500 | 2023-05-01 | 2023-03-23 | |
| Predictive Value of Maternal Blood Protein Signatures in Preterm Birth Preterm Birth | Completed | HBI Solutions Inc. | 18000 | 2021-01-01 | 2024-12-05 | |
| Maternal Serum Markers Predicting Preeclampsia At Early Gestations Blood test of PE risk, Blood test of Preterm PE risk - Pre-eclampsia, Preterm Birth | Completed | HBI Solutions Inc. | 18000 | 2019-01-01 | 2024-11-25 | |
| Pediatric Ventricle Function Assessment Study RV - Right Ventricular Abnormality, LV Dysfunction | Completed | HBI Solutions Inc. | 3993 | 2014-01-01 | 2024-12-20 |
Premature Birth (2) · Colorectal Neoplasms (1) · Hypertension, Pulmonary (1) · Mucocutaneous Lymph Node Syndrome (1) · Non-alcoholic Fatty Liver Disease (1) · Pre-Eclampsia (1) · Ventricular Dysfunction, Left (1)
China (2) · United States (1)
Hao Zhang, M.D (1) · Jianmin Niu, Master (1) · Junjie Peng, M.D (1) · Qiong Luo, M.D. Ph.D. (1)